Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation THT 2025

Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies

Presenter: Gregg Stone

February 13, 2025

Presentation THT 2025

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

Presenter: David Cohen

February 13, 2025

Presentation THT 2025

Burst Steroid Therapy and Quality of Life in Patients With Acute Heart Failure: Insights From the CORTAHF Trial

Presenter: Matteo Pagnesi

February 12, 2025

Presentation THT 2024

Impact Of Rapid Up-Titration of Guideline-Directed Medical Therapies On Quality of Life: Insights From The STRONG-HF Trial

Presenter: Kamile Cerlinskaite-Bajore

March 06, 2024

Presentation THT 2024

Participant-Centric, Digital, and Decentralized: What Are the Innovations We Need in How We Do Research?

Presenter: Harlan Krumholz

March 04, 2024

Presentation THT 2024

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Presenter: JoAnn Lindenfeld

March 04, 2024

Presentation THT 2023

Exercise Capacity and Health-Related Quality of Life With Furoscix: Data From the AT HOME Pilot Study

Presenter: Marvin Konstam

March 21, 2023

Presentation THT 2023

Can High Quality Hemodynamic Exercise Test Be Performed by a Majority of Heart Failure and Interventional Cardiologists?

Presenter: Ari Cedars

March 21, 2023

$Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?$

Presentation THT 2023

Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?

Presenter: Michael Sutherland

March 21, 2023

Presentation THT 2022

Spectrum of SGLT2-Inhibitor Benefits: Clinical to Symptoms to Quality of Life

Presenter: Javed Butler

February 01, 2022

Advertisement

Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

Burst Steroid Therapy and Quality of Life in Patients With Acute Heart Failure: Insights From the CORTAHF Trial

Impact Of Rapid Up-Titration of Guideline-Directed Medical Therapies On Quality of Life: Insights From The STRONG-HF Trial

Participant-Centric, Digital, and Decentralized: What Are the Innovations We Need in How We Do Research?

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Exercise Capacity and Health-Related Quality of Life With Furoscix: Data From the AT HOME Pilot Study

Can High Quality Hemodynamic Exercise Test Be Performed by a Majority of Heart Failure and Interventional Cardiologists?

Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?

Spectrum of SGLT2-Inhibitor Benefits: Clinical to Symptoms to Quality of Life

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content